Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
| Heron Therapeutics, Inc. |
| Mylan Pharmaceuticals Inc. |
| 1:2024cv00043 |
| January 11, 2024 |
| US District Court for the District of Delaware |
| William C Bryson |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 2, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc., Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Moore, David) |
| Filing 15 ANSWER to #1 Complaint ,Separate Defenses, and, COUNTERCLAIM against Heron Therapeutics, Inc. by Mylan Pharmaceuticals Inc..(Moore, David) |
| Case associated with lead case: Create association to 1:23-cv-01015-WCB. ALL FILINGS SHALL BE MADE IN THE LEADE CASE 1:23-cv-01015-WCB ONLY. (smg) |
Filing 14
STIPULATION AND ORDER consolidating cases. Signed by Judge William C. Bryson on 1/26/2024. Associated Cases: 1:23-cv-01015-WCB, 1:24-cv-00043-WCB(gva)
|
| Filing 13 Joint Letter to The Honorable William C. Bryson from Jeremy A. Tigan regarding Consolidation - re (12 in 1:24-cv-00043-WCB, 34 in 1:23-cv-01015-WCB) Stipulation. (Tigan, Jeremy) |
| Filing 12 STIPULATION and [Proposed] Order to Consolidate and Extend Time by Heron Therapeutics, Inc.. (Tigan, Jeremy) |
| Pro Hac Vice Attorney Christopher P. Hill,Mark Russell Sperling,Isaac S. Ashkenazi,Bruce M. Wexler for Heron Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
|
Filing 11
ORAL ORDER: The parties are directed to advise the court by letter whether this case is suitable for consolidation with Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc., No. 23-1015. The parties letters will be due for filing by January 26, 2024. Signed by Judge William C. Bryson on 1/20/2024. (gva)
|
|
Filing 10
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling filed by Heron Therapeutics, Inc. Signed by Judge William C. Bryson on 1/18/2024. (mpb)
|
| Filing 9 Pro Hac Vice Fee - Credit Card Payment received for Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling )( Payment of $ 200, receipt number ADEDC-4317723).(Tigan, Jeremy) |
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling - filed by Heron Therapeutics, Inc.. (Tigan, Jeremy) |
| Case Assigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit, due to related cases. Please include the initials of the Judge (WCB) after the case number on all documents filed. (rjb) |
| Filing 7 SUMMONS Returned Executed by Heron Therapeutics, Inc..Mylan Pharmaceuticals Inc. served on 1/12/2024, answer due 2/2/2024. (Tigan, Jeremy) |
| Filing 6 Summons Issued as to Mylan Pharmaceuticals Inc. on 1/11/2024. (vfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Heron Therapeutics, Inc.. (vfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See Attached. (vfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/18/2023. Date of Expiration of Patent: 09/18/2035.Thirty Month Stay Deadline: 6/18/2026. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Mylan Pharmaceuticals Inc. ( Filing fee $ 405, receipt number ADEDC-4312941.) - filed by Heron Therapeutics, Inc.. (Attachments: #1 Exhibit A-J, #2 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
